Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Treatment of TP53-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclax.
Journal: Haematologica
Published: January 13, 2026
What is the best induction for myeloma for the fit patient?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
Journal: JCO precision oncology
Published: July 25, 2025
Antibody Titers of Vaccine-Preventable Pathogens at 1 Year Post CD19 CAR-T Cell Therapy.
Journal: Transplantation and cellular therapy
Published: July 15, 2025
Discerning Progressive Immunotherapy-Related Mucocutaneous Eruption from Stevens-Johnson Syndrome: An International, Multicenter Case-Control Study.
Journal: Journal of the American Academy of Dermatology
Published: May 17, 2025
Tumor location as a risk factor for severe immune-related adverse events.
Journal: Journal for immunotherapy of cancer
Published: April 26, 2025
The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia.
Journal: Blood advances
Published: April 01, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.
Journal: JAMA network open
Published: March 27, 2025
Hidradenitis suppurativa through an intersectional lens.
Journal: Archives of dermatological research
Published: January 12, 2025
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.
Journal: Blood cancer journal
Published: January 11, 2025
Last Updated: 09/26/2026